lungs cancer

Advances in Lung Cancer

Although lung cancer is one of the most common cancer diseases in the United States, many people are unaware of their reach and impact. Did you know, for example, that lung cancer is the number one cause of cancer death among women, according to the American Lung Association (ALA)? Over the past 37 years, the rate of new lung cancer has doubled among women, and only 1 percent of women have the disease on the radar. The American Cancer Society believes that 221,200 new cases will be diagnosed by the end of the 2,015-115,610 men and 105,590 women. While cigarette smoking is an important factor, the 28,000 Americans with lung cancer live never smoked, according to the ALA. But it is good news. Today, thanks to a great deal to improve the diagnosis and treatment, thousands of people survive lung cancer. The key is too early to catch it if it had a much higher survival. However, most cases are diagnosed only later stages, the sensitization measures around the early detection efforts are increasingly important.

A medical advancement that offers oncologists new tools in the fight against lung cancer immunotherapy. It uses its own immune system to recognize the body and fight cancer cells. “Tumors have ways to protect themselves and ways to prevent natural protection of the body’s defense normally,” said Dr. Kendal Hervert, a pulmonologist in our clinic in Tulsa. “This therapy is a way to end the defenses.” Checkpoint inhibitors as pembrolizumab (Keytruda┬«), the president of Jimmy Carter to treat metastatic melanoma, which has spread to his liver and brain, acts by doing the body to do what it was designed to do. Think about the cancer cells as biological doubles. They possess the cells of the body mutated and turned against their hosts. But because they are not alien, they often sneak past defenses immune system. These doubles have a kind of false signals to send T-cells to fight antigen that they are not harmful. “Nothing to see here,” they cut on T cells that pass through various checkpoints in search of intruders. If it does not run amok for these checkpoints, t-cells, and healthy cells. But immunotherapy developed to disable these checkpoints and disrupt the cancer cells signaling them to unleash easy and the immune system attack.

“Cancer is like a wolf in sheep’s milk,” said Dr. Eugene Ahn, an oncologist at Cancer Therapy Centers of America┬« (CTCA) near Chicago. “The body as a member of the herd perceives helps.” This drug removes clothing sheep. ” Other forms of cancer immunotherapy has been used over the years, and more developed. Another development affects the use of targeted therapy, sharing or killing them directly on the growth blocks cancer caused by cancer cells. “Targeted therapies allow people to continue their daily lives because they do not have to go every two or three weeks for chemotherapy infusions,” said Dr. Hervert. “As a rule, it is a pill that takes them on a daily basis, and it allows them to have a little more feeling just as they are in their routine.” Further improvements in the field of diagnosis. For example, speed up diagnostic programs on how the in our Chicago area hospital and we Tulsa Hospital offered significantly for the amount of time that patients can wait for the test results. With the rapid lung node diagnostic program hospital, a medical team consisting of a medical oncologist, interventional radiologist, a pneumatologist and thoracic surgeon, all work together under one umbrella reviews relevant scans and records for the patient comes. If necessary photos, done a biopsy that day and immediately checked by a pathologist. On the fourth day of diagnosis of the medical team to share and found as cancer, recommends an individual treatment plan designed specifically to the needs of the patient. “We think it will improve the quality of care as an early diagnosis is made effective, and it will be the emotional and psychological stresses that go with it to know that something is wrong and I do not need to have a treatment plan “Said Dr. Bruce Gershenhorn, medical oncologists in our clinic outside of Chicago.